Blocking the absorption of cholesterol in the treatment of hyperlipidemia--old and new ways of treatment
Vanhanen, H.
Duodecim; Laaketieteellinen Aikakauskirja 120(9): 1105-1110
2004
ISSN/ISBN: 0012-7183 PMID: 15232853 Document Number: 570706
Document emailed within 1 workday
Related Documents
Elcarte López, R.; Villa Elizaga, I.; Sada Goñi, J.; Gascó Eguiluz, M.; Oyarzabal Irigoyen, M.; Sola Mateos, A.; García Ibero, C.; Elcarte López, T.; Ferrer Giménez, M.; Fonteneda Estíbaliz, A. 1993: Study from Navarra. Hyperlipidemia II. Variations according to age and sex in the average cholesterol level, LDL-cholesterol and triglycerides in an infant-child population Anales Espanoles de Pediatria 38(2): 159-166Schauer, I.; Schauer, U.; Rühling, K.; Thielmann, K. 1980: The effect of propranolol treatment on total cholesterol, HDL cholesterol, triglycerides. Postheparin lipolytic activity and lecithin:cholesterol acyltransferase in hypertensive individuals Artery 8(2): 146-150
Gromkowski, S.H.; Heagy, W.; Sanchez-Madrid, F.; Springer, T.A.; Martz, E. 1983: Blocking of CTL-mediated killing by monoclonal antibodies to LFA-1 and LYT-2,3. I. Increased susceptibility to blocking after papain treatment of target cells Journal of Immunology 130(6): 2546-2551
Jolley, C.D.; Dietschy, J.M.; Turley, S.D. 1999: Genetic differences in cholesterol absorption in 129/Sv and C57BL/6 mice: effect on cholesterol responsiveness American Journal of Physiology 276(5): G1117-G1124
Reisser, D.; Boquillon, M.; Clément, J. 1980: Comparison between cholesterol and phosphatidylcholine intestinal absorption from native bile labelled with [1-2 3H] cholesterol and [1-14C] palmitic acid in the rat Journal de Physiologie 76(8): 865-870
Simon, B.; Bergemann, W.; Bouzo, H.; Hüttemann, W.; Hotz, F.; Müller, P.; Rösch, W. 1991: Prokinetic drug treatment (cisapride) is as effective as H2-blocking agent (ranitidine) in the treatment of gastric ulcer Hepato-Gastroenterology 38(Suppl 1): 41-45
Haraldsen, M. 1996: Treatment of hyperlipidemia Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 116(1): 112
Kaffarnik, H. 1982: Is there an age limit in the treatment of hyperlipidemia? Die Medizinische Welt 33(17): 651
Stone, W.L.; Chin, T.K. 2001: Drugs for the treatment of hyperlipidemia Idrugs: the Investigational Drugs Journal 4(7): 788-794
Noseda, G. 1990: Drug treatment of hyperlipidemia Therapeutische Umschau. Revue Therapeutique 47(6): 499-508
Maxwell, M.H.; Heber, D. 1990: Nutritional treatment of hyperlipidemia and obesity Cardiovascular Clinics 20(3): 149-156
Tonstad, S.; Leren, T.P.; Ose, L. 1997: Diagnosis and treatment of severe hyperlipidemia Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 117(29): 4241-4244
Weintraub, M.; Grosskopf, I.; Rubinstein, A. 1995: Principles of dietary treatment in hyperlipidemia Harefuah 128(9): 556-561
Martina, B.; Weinbacher, M.; Kiener, S.; Keller, U.; Battegay, E. 1996: Reproducibility of fasting serum cholesterol and triglycerides in ambulatory patients with mixed hyperlipidemia Schweizerische Medizinische Wochenschrift 126(50): 2175-2180
Beermann, B.; Hellström, K. 1970: Absorption ways of digoxin and digitoxin Nordisk Medicin 84(38): 1212
Tanaka, K.; Honjo, H. 2001: Clinical feature and treatment of the postmenopausal hyperlipidemia Nihon Rinsho. Japanese Journal of Clinical Medicine 59(Suppl 3): 766-770
Stratmann, F.W. 1982: What are the possibilities in the treatment of primary hyperlipidemia in diabetes mellitus? Die Medizinische Welt 33(17): 651
Resnicow, K.; Cross, D. 1993: Are parents' self-reported total cholesterol levels useful in identifying children with hyperlipidemia? An examination of current guidelines Pediatrics 92(3): 347-353
Panchenko, V.M.; Ershov, A.A.; Isaev, V.A.; ZImovchenko, G.S.; Chernova, G.I. 2001: Poseidonol in the treatment of hyperlipidemia in patients with type 2 diabetes mellitus Klinicheskaia Meditsina 79(6): 47-49
Boberg, J.; Gustafson, A. 1970: Serum-lipid reducing principles--possibilities for treatment. 2. Classification of hyperlipidemia Lakartidningen 67: Suppl Iv: 40+